The Pharmaceutical Journal
Vol 276 No 7398 p495
29 April 2006

This article
Reprint   Photocopy

  Acrobat Reader

News summary

MHRA calls for proposals on ways to evaluate patient yellow card reporting

Success of the yellow card scheme initiative that allows patients to report suspected adverse drug reactions will be assessed in a two-year, £200,000 project, the Medicines and Healthcare products Regulatory Agency announced this week.

The MHRA, together with the National Co-ordinating Centre for Research Methodology, is calling for proposals on ways to evaluate the patient-reporting component of the scheme.

Further details on how to submit proposals. Proposals must be received by 16 June.